Mouginot, Didier, Samuel B. Kombian, and Quentin J. Pitt-review, see Renaud and Bourque 1991) . Among the neuroman. Activation of presynaptic GABA B receptors inhibits evoked transmitters, immunocytochemistry has identified both glutaIPSCs in rat magnocellular neurons in vitro. J. Neurophysiol. 79: matergic and GABAergic terminals inside the SON (Gies 1508 (Gies -1517 (Gies , 1998 . Whole cell recordings (nystatin-perforated and Theodosis 1994; Theodosis et al. 1986 ; Van den Pol patch) were carried out on magnocellular neurons of the rat su-1991), and electrophysiological studies performed both in praoptic nucleus (SON) fen reversibly reduced the amplitude of the IPSCs in a dose-dependent manner (EC 50 : 0.68 mM) without apparent effect on the hold-Modulating this fast synaptic transmission is another way to ing current (V h Å 080 mV) or input resistance and altered neither control neuronal excitability and activation of presynaptic the kinetic properties, nor the reversal potential of IPSCs. Concom-receptors was shown to be a powerful mechanism for achievittant to IPSC depression, baclofen enhanced the paired-pulse ratio ing this in many brain areas (for review, see Nicoll et al. for two consecutive IPSCs [interstimulus interval (ISI): 50 ms], 1990). In particular, presynaptic g-aminobutyric acid-B an effect consistent with a presynaptic locus of action. Both actions (GABA B ) receptors were shown to reduce the release of of baclofen were abolished by CGP35348 (500 mM), a GABA B both excitatory and inhibitory neurotransmitters (for review, receptor antagonist. In testing for involvement of synaptically actisee Misgeld et al. 1995) . In the SON, autoradiographic studvated presynaptic GABA B receptors, we only recorded paired-pulse ies reported the presence of GABA B receptors (Bowery et facilitation at most ISIs tested (50-500 ms), suggesting that the Chu et al. 1990 ) and a recent study demonstrated classical GABA B autoreceptors may not normally be activated in our conditions. However, enhancement of local GABA concentra-the inhibition of excitatory postsynaptic currents (EPSCs) tion by perfusion of a GABA uptake inhibitor (NO-711) revealed by activation of GABA B receptors located on glutamatergic an action of endogenous GABA at these presynaptic GABA B recep-terminals . Because g-aminobutyric tors. The nonselective K / channel blocker Ba 2/ abolished baclo-acid (GABA)-positive terminals also synapse onto SON fen's effect and pertussis toxin (PTX) pretreatment (200-500 ng/ magnocellular neurons (Decavel and Van den Pol 1990), in ml for 18-24 h) was ineffective in blocking the baclofen-induced the present study we investigated a possible modulation of inhibition, making an involvement of PTX-sensitive G protein un-GABA release via activation of GABA B receptors in an in likely. The present results show that presynaptic GABA B receptors vitro hypothalamic slice preparation, by using the nystatinthat are coupled to PTX-insensitive G-proteins may be activated perforated patch technique.
by endogenous GABA under conditions of reduced GABA uptake, thus regulating the inhibitory synaptic input to SON.
M E T H O D S I N T R O D U C T I O N
All experiments were carried out in accordance with the guidelines established by the Canadian Council on Animal Care and were
The supraoptic nucleus (SON) of the hypothalamus is approved by the University of Calgary Animal Care Committee. composed of two different populations of magnocellular neurons that synthesize either oxytocin (OT) or arginine-Slice preparation vasopressin (AVP) hormones. These neuropeptides are anterogradely transported to the neural lobe of the pituitary Sprague-Dawley rats (180-250 g) were anesthetized with haloand released into the circulation to play an important role in thane and decapitated. The brain was quickly removed and placed in ice-cold, carbogenated (95% O 2 -5% CO 2 ) artificial cerebrospinal the regulation of physiological functions like hydromineral fluid (ACSF). Coronal slices (400 mm thick) were cut with a balance, parturition, and lactation. Release of OT and AVP vibratome, from a block of tissue containing the hypothalamus, in is directly correlated to the electrical activity of SON neurons cold (4ЊC) carbogenated ACSF. Hypothalamic slices containing (Poulain and Theodosis 1988) and neuromodulators that the SON were then taken, hemisected along the midline and incufinely tune the firing rate and pattern of the neurosecretory bated in ACSF at room temperature (21ЊC) for at least 2 h before cells also regulate secretion of OT and AVP. Neurons located recording. A slice was transferred into a recording chamber where in many brain areas project to the SON (Anderson et al. it was submerged and continuously perfused with prewarmed 1990), and thus alteration of the excitability of magnocellu-ACSF (27-29ЊC) at a rate of 2-3 ml/min. The composition of lar neurons could be achieved by neurotransmitter-mediated the ACSF was (in mM) 126 NaCl, 2. 
Nystatin-perforated patch recordings
Axon Instruments). As inhibitory postsynaptic current (IPSC) size To maintain the integrity of the intracellular contents, whole cell showed variability, several IPSCs (6-20) were averaged for each recordings from SON neurons were made with the perforated-patch data point. technique by using nystatin as the perforating antibiotic. Glass
The amplitude of the IPSCs was taken as a measure of the micropipettes (tip resistance 5-7 MV) were filled with a solution magnitude of synaptic strength. Data were expressed as percentage containing (in mM) 120 potassium acetate, 40 N-2-hydroxyethylpi-change from control values as mean percentage { SE. Cells served perazine-N-2-ethanesulfonic acid (HEPES), 5 MgCl 2 , 10 ethyl-as their own controls and only cells that showed significant recovene glycol-bis(b-aminoethyl ether)-N,N,N,N-tetraacetic acid ery (ú70%) from any drug effect (except NO-711) were included (EGTA), and 450 mg/ml nystatin. The nystatin solution was pre-in the analysis. Statistical comparisons were performed by using pared in dimethyl sulfoxide (DMSO) and pluronic FC before incor-analysis of variance (ANOVA) and paired or unpaired Student's poration in the previous solution.
t-tests. P õ 0.05 was considered significant. High-resistance seals (1-5 GV) were made by using either an Calculation of the EC 50 for baclofen was done by fitting the Axopatch 1D, or an Axopatch 200 patch-clamp amplifier (Axon experimental data to the following Hill equation that provided the Instruments, Foster City, CA) in voltage-clamp mode, and the fast best fit to the data electrode capacitance was then compensated. Adequate access to the cell (access/series resistance of 10-30 MV) was attained in Tasker and Dudek 1991) were included in this study.
Chemical compounds
Synaptic currents were evoked in SON neurons with a bipolar stimulating electrode placed in the hypothalamic region dorsomedAll drugs were applied by bath perfusion. All substances were ial to the SON, close to the optic tract, and connected to a stimulus prepared as stock solution in distilled water or appropriate solvent isolation unit. Square pulses (100-200 ms) of an intensity that and diluted to their final concentration in ACSF just before use. yielded a response 50-60% of the maximum response (10-20 V) CGP35348 and ({)-baclofen were gifts from Ciba-Geigy. Pluronic were used for the experiments.
FC was from BASF Wyandotte (Michigan). Picrotoxin, bicuculThe magnocellular SON neurons were voltage-clamped at 080 line, kynurenic acid, and nystatin were obtained from Sigma (St. or 060 mV and transient hyperpolarizing voltage steps to 0100 Louis, MO). NO-711 was purchased from RBI (Natick, MA). mV (300-800 ms) were applied to both monitor the input resistance and improve the driving force of the inhibitory currents. The electrical stimulation of the afferent fibers was evoked during the R E S U L T S hyperpolarizing pulses with a 150 ms delay or a 50 ms delay for the repetitive stimulation experiments.
Results described in this study were collected from 97
The synaptic currents were sampled with the software pClamp magnocellular neurons of the hypothalamic supraoptic nu- 
Characterization of evoked IPSCs recorded in
Taken together, these results demonstrate that electrical stimulation of afferent fibers to the SON in the presence magnocellular neurons of a glutamate receptor antagonist elicits pharmacologically Under control condition, extracellular stimulation of the isolated GABA A receptor-mediated monosynaptic IPSCs in hypothalamic region dorsomedial to the SON and close to magnocellular neurons. the optic tract, elicited a fast postsynaptic inward current in magnocellular neurons maintained at a holding potential of Baclofen reduces the amplitude of evoked IPSCs 080 mV. In the presence of kynurenic acid (1 mM), a nonspecific blocker of the ionotropic excitatory amino acid To record IPSCs in isolation, kynurenic acid (1 mM) was always present in the extracellular solution. Bath application receptors, the amplitude of the postsynaptic current was reduced by 56.3 { 3.9% (n Å 28). Under these experimental of baclofen (10 mM), an agonist for the GABA B receptor, reduced the amplitude of evoked IPSCs by 95.4 { 4.8% (n Å conditions and when neurons were transiently (300 ms) voltage clamped at 0100 mV, the inward currents were graded, 8; Fig. 2 A, left) . The onset of the effect was fast, and the maximal inhibition was achieved in 3-5 min. The baclofenshowing a single peak for different stimulus intensities and were always evoked with a fixed latency, thus indicating mediated effect was reversible on washout of the drug ( Fig.  2A, right) , showing Ç70% recovery after 10 min. monosynaptic inhibitory connections (Fig. 1A) .
These currents were almost completely blocked by either At a stimulus intensity that yielded 50-60% of the maximum IPSC, baclofen reduced the IPSC amplitude in a dose-50 mM picrotoxin (88.3 { 5.4% reduction; n Å 6), or 25 mM bicuculline (89.5 { 2.8% reduction; n Å 7), two antago-dependent manner (Fig. 2B) , with an EC 50 of 0.68 mM calculated from a four variable Hill equation that best fitted nists of the GABA A response (Fig. 1B) , demonstrating that these currents were mediated by the movement of chloride the experimental data (see METHODS ). Baclofen also depressed the IPSCs over a wide range of stimulus intensities, ions through GABA A receptors present on magnocellular neurons. The current-to-voltage relationship of these inhibi-which is related to the synaptic strength. Input-output responses ranging from subthreshold to maximal IPSC amplitory postsynaptic currents (IPSCs) was determined in 16 cells and showed a reversal potential of 058 { 1.9 mV tude were generated in five cells. In all of them, bath-applied baclofen (0.3 mM) reduced the amplitude of the graded (Fig. 1C) IPSCs, with greater inhibition observed at higher stimulus 0.05; Fig. 4A ), making it unlikely that a postsynaptic action of baclofen modulates IPSCs. Second, a possible interaction intensities (Fig. 2C) . The baclofen-induced inhibition of evoked IPSCs did not desensitize because two consecutive between g-aminobutyric acid-A (GABA A ) and GABA B receptors was investigated by evaluating the biophysical propapplications of baclofen (1 mM) reduced the amplitude of the IPSCs by 59 { 7% and 53 { 8%, respectively (n Å 5; erties of the evoked IPSCs under control condition and in the presence of baclofen. P ú 0.05; data not shown).
In control, the activation time constant (time to peak) and the decay of the evoked IPSCs could be both fitted to a Baclofen reduces the IPSC amplitude by activation of monoexponential function, giving time constants of 2.6 { GABA B receptors 0.4 ms and 13.5 { 0.8 ms, respectively (n Å 11). In the We investigated the specificity of the baclofen-induced presence of baclofen (0.3 mM), the time to peak was 2.7 { reduction of the evoked IPSCs by using a competitive 0.3 ms and the decay time constant was of 14 { 1.1 ms, GABA B receptor antagonist, CGP35348, to block the baclo-values that were not statistically different from those obfen-induced inhibition. Baclofen (0.3 mM) reduced the am-tained in control condition (P ú 0.05; Fig. 4B ). Finally, plitude of the evoked IPSCs by 53.3 { 1.6% in four cells the reversal potential of the evoked IPSCs (E rev IPSC), was tested (Fig. 3) . In the same cells, ACSF containing 500 mM determined under control condition and in the presence of of CGP35348 was perfused for 5-10 min before and during baclofen. In control the E rev IPSC was 057 { 1.6 mV comapplication of baclofen (0.3 mM). Under this condition, pared with 057 { 1.5 mV and 057 { 3.6 mV in the presence baclofen reduced the amplitude of the IPSCs by only of baclofen 1 and 5 mM, respectively (n Å 5; P ú 0.05), 13.5 { 4.1% (P õ 0.05; Fig. 3 ). On its own, CGP35348 indicating baclofen had no effect on E rev IPSC (Fig. 4C) . induced a small, but statistically insignificant increase in Taken together, these results demonstrate that baclofen IPSC amplitude (11.3 { 5.0%), without any detectable inhibits the amplitude of evoked IPSCs without affecting change in the holding current (Fig. 3) .
either the kinetic properties or the reversal potential of the Our data show that baclofen-induced inhibition of evoked IPSCs. IPSCs was achieved by activation of GABA B receptors.
Baclofen-mediated inhibition of IPSCs involves activation Baclofen has no apparent postsynaptic effects on SON of presynaptic GABA B receptors neurons
The previous observations showing that baclofen has no apparent postsynaptic effects on the magnocellular neurons sugThe baclofen-induced reduction in the amplitude of evoked IPSCs may be the result of an action of baclofen at gested that the inhibition of the evoked IPSCs was probably mediated by presynaptic GABA B receptors. At excitatory synthe postsynaptic level. To test this hypothesis, different sets of experiments were performed. First, bath application of a apses studied in this nucleus, baclofen was shown to increase the paired-pulse ratio (PPR) of two consecutive responses [inhigh concentration of baclofen (5 mM) neither modified the holding current, nor changed the input resistance of recorded terstimulus interval (ISI) 50 ms], indicating a change in glutamate release . Therefore, to test for a magnocellular neurons (800 { 213 MV in control vs. 779 { 228 MV in the presence of baclofen; n Å 5, P ú presynaptic locus of action for baclofen, we tested whether or J545-7 / 9k25$$fe08 02-18-98 09:30:53 neupa LP-Neurophys we tested the effect of CGP35348 (500 mM) on the baclofeninduced change in PPF. In the presence of this GABA B receptor antagonist, baclofen (0.3 mM) only slightly reduced the amplitude of the first IPSC (13.5 { 4.1%; P ú 0.05 compared with control), without enhancing PPF (0.5 { 2.5%; P ú 0.05 compared with control, Fig. 5 ). Taken together, these results are consistent with baclofen reducing the amplitude of evoked IPSCs via presynaptic GABA B receptor activation.
Presynaptic GABA B receptors are activated by endogenously released GABA in the presence of a GABA uptake inhibitor
To determine whether or not GABA released from the inhibitory terminals acts retrogradely to inhibit its own release via activation of the previously characterized presynaptic GABA B receptors, the paired-pulse profile with 50-60% of maximal IPSC amplitude was tested at different ISIs (ranging from 50 to 500 ms). For ISI of 100 ms, significant increase in the amplitude of the second IPSC was recorded (PPR 1.4 { 0.05, n Å 12), as previously observed at ISI of 50 ms (PPR 1.6 { 0.07, n Å 12). For ISI of 200 and 500 ms, PPR was near unity (1.1 { 0.1, n Å 10 and 1.0 { 0.1, n Å 6, respectively; Fig. 6 , A-C). To test whether or not the observed facilitation of the second IPSC depended on the synaptic strength and therefore on a putative heterogeneity in the inhibitory fibers recruited, we applied a graded stimulus intensity at an ISI of 50 ms. In five neurons tested, weak to moderate stimulus intensities (10-60% of the intensity giving the maximal IPSC amplitude) always showed an increase of the second IPSC size. For maximal stimulus intensities, PPF was reduced, but no PPD was recorded (Fig. 6B) . not it would alter the PPR between two IPSCs evoked at ISI of 50 ms (PPR: amplitude of the IPSC 2/amplitude of the IPSC 1) whereby a PPR greater than unity indicates paired-pulse facilitation (PPF) and PPR less than unity indicates paired-pulse depression (PPD). Because of the variability in the amplitude of evoked IPSCs, stimulus intensities giving 50-60% of the maximal IPSC amplitude were used to test the PPR paradigm. This level of synaptic transmission allowed changes in both IPSC amplitudes to occur without saturating the second response. In 12 magnocellular neurons tested, all displayed an increase in IPSC by 49.6 { 3.2%. Concurrent with this decrease, the PPR (500 mM) tested in the same cell ( bottom). B: effects in A obtained from was enhanced to 2.1 { 0.13, a facilitation of 32 { 5.8% (P õ several cells. Number above each bar represent number of cells tested.
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35348 (500 mM), NO-711 decreased the amplitude of the evoked IPSCs by only 12.0 { 5% (P õ 0.05, compared with unpaired test, Figs. 7, C and D) . In addition, in the presence of CGP35348, NO-711 enhanced PPF by only 10 { 7.5%, a value that is significantly different from the depression induced by NO-711 alone (P õ 0.05, n Å 6; unpaired test, Fig. 8, B and C) . These results show that presynaptic GABA B receptors could be activated in the presence of a GABA uptake inhibitor to reduce inhibitory synaptic transmission.
Additional pharmacology of the presynaptic GABA B receptors involved in IPSC reduction
Our experiments provided evidence that baclofen affects the inhibitory synaptic transmission in the SON via a presynaptic decrease in evoked GABA release. A proposed mechanism of action of baclofen has been for it to modulate ionic conduc- Release of GABA during the paired-stimulation protocol may not reach a sufficient concentration to activate the presynaptic GABA B receptors. To enhance the concentration of GABA in the synaptic cleft, we evoked IPSCs in the presence of NO-711, an inhibitor of both glial and neuronal GABA uptake (Suzdak et al. 1992) . Bath application of NO-711 (10 and 50 mM) reduced the amplitude of the evoked IPSC by 41 { 5% (n Å 9; P õ 0.05 compared with control, Fig. 7,  A and D) . NO-711 did not trigger an inward current at 080 mV holding potential, neither did it change the input resistance of SON cells (789 { 145 MV in control vs. 719 { 146 MV in the presence of NO-711; n Å 9; P ú 0.05; Fig. 7B ). In (Fig. 7A, right) . The depression of the evoked IPSC changing decay of IPSCs (right, average of 12 sweeps). Note that IPSC was, however, accompanied by an enhancement in PPF of amplitude in presence of NO-711 ( ---) was scaled to control IPSC 69 { 18% (n Å 9; P õ 0.05 compared with control; Fig. 8, ( ) for comparison. B: a chart record showing that NO-711 has no effect A and C), an effect similar to baclofen. Under our recording either on holding current of an SON cell held at 080 mV or on input resistance of cell, as indicated by averaged membrane currents (4 sweeps) represented conditions, the effects of NO-711 (10 and 50 mM) did not at an expanded time scale. C : superimposed traces obtained from the same recover after 10-30 min washing out of the drug. 711-induced inhibition of the IPSCs. In the presence of CGP J545-7 / 9k25$$fe08 02-18-98 09:30:53 neupa LP-Neurophys fen-induced effect may be because of the lack of activity of the toxin itself. To test this possibility, we used lateral parabrachial nucleus (LPBN) slices (Saleh et al. 1996) . We previously observed that LPBN neurons possessed postsynaptic GABA B receptors that are coupled to a PTX sensitive G-protein, which induces an outward current in these neurons when voltage-clamped at 065 mV (S. B. Kombian, unpublished observation). Slices containing the LPBN were therefore concurrently incubated with SON slices in ACSF containing PTX (500 ng/ml) for 18 h. Under these experimental conditions, baclofen (10 mM) no longer triggered the outward current in LPBN cells (n Å 4, data not shown), while still depressing EPSCs that are PTX insensitive.
D I S C U S S I O N
Field stimulation of the hypothalamic region dorsomedial to the SON elicited pharmacologically isolated IPSCs. These synaptic currents resulted from the activation of GABA A receptors, as shown by their almost complete abolition by either picrotoxin or bicuculline. On the basis of the fact that permeability of chloride ions through the nystatin-generated pores is not negligible (for review, see Akaike and Harata 1994) , the reversal potential of the IPSCs (approximately 060 mV) was slightly different from the theoretical E Cl calculated for our experimental conditions using the Nernst equation (067 mV). This small discrepancy may be explained by a leak of bicarbonate ions through the GABA A receptor complex, as a result of using a bicarbonate-buffered ACSF (Staley et al. 1995) . Baclofen, a GABA B receptor agonist, dose-dependently significance at P õ 0.05 compared with . Note that traces are average of 12-20 sweeps.
decreased the IPSC amplitude in a reversible manner. This depression was prevented by a competitive GABA B receptor antagonist, CGP35348, further demonstrating the involvetances. Thus we investigated the involvement of presynaptic K / conductances in the inhibition of the evoked IPSCs. In ment of GABA B receptors in the baclofen-induced inhibition of inhibitory synaptic transmission. control condition, bath application of barium (1 mM), a nonselective K / channel blocker, slightly increased the amplitude A number of postsynaptic mechanisms could account for the reduction in the IPSC amplitude observed in neurosecreof evoked IPSCs by 9.7 { 2.6% (n Å 7, data not shown). In its presence, baclofen (0.3 mM) only weakly reduced the tory cells in response to baclofen. First, baclofen could activate postsynaptic GABA B receptors, which in turn could amplitude of the IPSCs by 8.9 { 1.3% (n Å 7), compared with the baclofen-induced IPSC reduction of 41.8 { 8.5% modulate the GABA A receptor-mediated response. However, this possibility is unlikely to account for the observed reducrecorded under control conditions (P õ 0.05; Fig. 9A ).
Furthermore we investigated the possible coupling of the tion in the IPSC amplitude because baclofen neither changed the holding current, nor the input resistance of rat magnocelpresynaptic GABA B receptors to ionic conductances via a pertussis toxin (PTX) sensitive G-protein. Slices were hemi-lular cells, a result supported by previous findings Wuarin and Dudek 1993) . Second, GABA B sected along the midline and one-half was incubated, at room temperature, in ACSF containing PTX (200 ng/ml) over 18 receptors could modify the function of postsynaptic GABA A receptors, so that the postsynaptic response to a given h. The other hemislices were incubated in regular ACSF for the same period of time. In control slices, baclofen (1 mM) amount of GABA is decreased. In cerebellar granule cells, baclofen was shown to inhibit muscimol-induced 36 Cl 0 upreduced the IPSC amplitude by 48.1 { 5.3% (n Å 10, Fig.  9B1 ). In PTX treated slices, baclofen-induced inhibition of take (Hahner et al. 1991) , suggesting a change in chloride channel function. Although activation of GABA B receptors IPSC amplitude was still 49.2 { 3.4% (n Å 11, Fig. 9B2 ), which is not statistically different from control (P ú 0.05). may modify the function of GABA A receptors in certain neurons, our data on IPSC kinetics and reversal potential When the concentration of PTX was raised to 500 ng/ml for the same period of time (18 h), baclofen (1 mM) was demonstrate that there is no evident interaction between postsynaptic GABA A and GABA B receptors in SON neurosecrestill able to reduce the IPSC amplitude by 52.8 { 1.3% (n Å 4; P ú 0.05; data not shown).
tory cells, as is the case in hippocampal (Harrison et al. 1988 ) and neocortical neurons (Howe et al. 1987) . The lack of effect of the PTX pretreatment on the baclo-J545-7 / 9k25$$fe08 02-18-98 09:30:53 neupa LP- Neurophys FIG . 9 . Pharmacology of baclofen-induced inhibition of evoked IPSCs. A: barium (1 mM) blocked baclofen-induced inhibition of evoked IPSCs in a reversible manner. B2: incubation of slices in pertussis toxin (500 ng/ml) over 18 h did not abolish baclofen-induced inhibition of evoked IPSCs that was seen in other hemisected slices incubated for identical times under control condition (B1).
Location of the presynaptic GABA B receptors: possible tra-hypothalamic inhibitory fibers and local axons from the inhibitory interneurons in the PNZ. Therefore the GABA B involvement of a polysynaptic network receptors responsible for the disinhibition of the magnocelluDespite the fact that a prominent GABAergic input to the lar cells could be found on the somata of the inhibitory SON was described (for review, see Armstrong 1995; Re-interneurons and/ or on the inhibitory terminals of the naud and Bourque 1991), the source of this innervation GABAergic afferents. remains unclear. Although an electrophysiological study combined with excitotoxic lesions indicated monosynaptic Location of the presynaptic GABA B receptors on connections from GABAergic neurons located in the median inhibitory interneurons preoptic area ), axonal transport and immunohistochemical methods concluded that direct
The GABA B receptors could be found on the somata of the inhibitory interneurons located in the PNZ. A baclofenGABAergic projections from brain areas to the SON are a minor component of this innervation. The proposition of induced hyperpolarization and conductance changes could reduce the number of these interneurons reaching the spike GABAergic interneurons located in the perinuclear zone (PNZ) and projecting to the neurosecretory cells appears threshold, thereby affecting the release of GABA (Misgeld et al. 1989) . The fact that the baclofen-induced decrease in well accepted (Jhamandas et al. 1989; Roland and Sawchenko 1993) . Considering this anatomic situation and the IPSC amplitude was abolished in the presence of barium could suggest that the GABA B receptors involved in the finding that polysynaptic IPSPs are depressed to a greater extent by baclofen than monosynaptic IPSPs (Mott et al. inhibitory effect are linked to a K / conductance, like the one present on CA3 pyramidal cells (Gähwiler and Brown 1993; Thompson and Gähwiler 1992) , the baclofen-induced depression of IPSCs evoked by electrical stimulation of the 1985) or neurons of the locus coeruleus (Osmanovic and Shefner 1988) . These postsynaptic GABA B receptors are zone dorsomedial to the SON could be secondary to the depression of the excitatory inputs to the GABAergic inter-usually coupled to K / channels via a PTX sensitive Gprotein (Andrade et al. 1986; Colmers and Pittman 1988;  neurons. However, this hypothesis is unlikely to explain the baclofen-induced decrease of IPSC amplitude in SON slices Dutar and Nicoll 1988; Thalmann 1988) . However, our data demonstrate that PTX pretreatment of slices does not affect because all the experiments were carried out in the presence of kynurenic acid, a broad spectrum blocker of ionotropic the baclofen-induced depression of IPSCs under the same conditions where it blocked the postsynaptic GABA B reexcitatory amino acid receptors. Nevertheless, we cannot eliminate the possibility that our electrical stimulation acti-sponse in neurons of the LPBN (S. B. Kombian, unpublished observation). vated excitatory inputs to interneurons that do not utilize glutamate as a transmitter.
The block of K / conductances and subsequent enhanced Ca 2/ entry could also mask a baclofen-induced inhibition The pharmacologically isolated IPSCs showed a constant latency, a single peak over a range of stimulation intensities of Ca 2/ conductances activated during depolarization of the cell. The reduction in somatic Ca 2/ current amplitude, howand exhibited a monophasic decay. These results indicate that these IPSCs result from monosynaptic activation of ever, seems unlikely, based on the PTX insensitivity of baclofen's action. Indeed, in CNS neurons, the GABA B remany synapses, presumably formed by projections from ex-
